Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Editas Medicine, Inc. Director's Dealing 2016

Feb 2, 2016

33260_dirs_2016-02-02_72dd37fd-ea41-4256-8365-ab1b1573e427.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-02

Reporting Person: Cole Douglas G. (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct

Footnotes

F1: Mr. Cole does not own shares in his individual capacity. He is a non-controlling member of Flagship Ventures Fund IV General Partner LLC, the general partner of Flagship Ventures Fund IV, L.P. ("Flagship IV") and Flagship Ventures Fund IV-Rx, L.P. ("Flagship IV-Rx"). Flagship IV and Flagship IV-Rx are each a reporting person and each has filed a Form 3 reporting its respective ownership. Mr. Cole disclaims beneficial ownership of the shares owned by Flagship IV and Flagship IV-Rx, except to the extent of his pecuniary interest therein.